Navigation Links
Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Six Years With Similar Safety Profile Observed in Original Fracture Trial
Date:11/5/2011

policies may affect the development, usage and pricing of our products. In addition, we compete with other companies with respect to some of our marketed products as well as for the discovery and development of new products. We believe that some of our newer products, product candidates or new indications for existing products, may face competition when and as they are approved and marketed. Our products may compete against products that have lower prices, established reimbursement, superior performance, are easier to administer, or that are otherwise competitive with our products. In addition, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors and there can be no guarantee of our ability to obtain or maintain patent protection for our products or product candidates. We cannot guarantee that we will be able to produce commercially successful products or maintain the commercial success of our existing products. Our stock price may be affected by actual or perceived market opportunity, competitive position, and success or failure of our products or product candidates. Further, the discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations.

The scientific information discussed in this news release relating to new indications for our products is preliminary and investigative and is not part of the labeling approved by the U.S. Food and Drug Administration (FDA) for the products. The products are not approved for the investigational use(s) discussed in this news release, and no conclusions can or should be drawn regarding the safety or effectiveness of the products for these uses. Only the FDA can determine whether the products are safe and ef
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. FDA Approves New Indications for Prolia® (Denosumab) for the Treatment of Bone Loss in Patients With Prostate or Breast Cancer Undergoing Hormone Ablation Therapy
2. Prolia® (Denosumab) Phase 2 Extension Study Showed Continued Increase in Bone Mineral Density Over Eight Years of Treatment
3. Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate
4. Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Five Years of Treatment With Similar Safety Profile Observed in Pivotal Trial
5. XGEVA® (Denosumab) Granted Marketing Authorization in the European Union
6. Amgen Receives CHMP Positive Opinion for XGEVA™ (Denosumab) in the European Union
7. Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer
8. The Journal of Clinical Oncology Publishes Phase 3 XGEVA™ (Denosumab) Results in Advanced Cancer Patients With Solid Tumors or Multiple Myeloma
9. XGEVA™ (Denosumab) Significantly Improved Bone Metastasis-Free Survival in Men With Prostate Cancer
10. Amgen Presents New XGEVA™ (Denosumab) Breast Cancer Skeletal-Related Event Prevention Data at SABCS
11. Prolia™ (denosumab) Receives Best New Drug Honor at Scrip Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... OAKS, Calif. , July 30, 2015  Amgen (NASDAQ: ... Hassan , partner and managing director of Warburg Pincus LLC, ... are pleased to welcome Fred Hassan and the ... the Amgen Board," said Robert A. Bradway , chairman ... and commitment to innovation will serve Amgen well." ...
(Date:7/30/2015)... FALLS, Ohio , July 30, 2015  Cleveland ... his OMTEC® 2015 keynote address last month that industry ... models in order to gain the efficiencies—and develop the ... Dr. Barsoum,s comments were preceded by ... avid entrepreneur and OMTEC moderator, who stressed that industry ...
(Date:7/30/2015)... 30, 2015  Growth of the U.S. nonprescription market ... former prescription users to the OTC market. Due to ... robust Rx-to-OTC switch activity over the next five years ... many new brands entering the market into existing categories. ... five years (even those with low to moderate likelihood), ...
Breaking Medicine Technology:Amgen Announces Appointment Of Fred Hassan To Board Of Directors 2Amgen Announces Appointment Of Fred Hassan To Board Of Directors 3Orthopaedic Surgery Reimbursement Shifts to Episode of Care 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 3
... 16, 2011 White Smile Global Inc. (OTCBB: WSML) ... update on the Company. Upon appointment of ... Giniger DMD, PhD, MsD, FICD, the Company has recently ... have been purchased in full from the world renowned Bio-Chemist. ...
... 2011 Healthcare Quality Catalyst Corp. ( www.hqcatalyst.com ), ... series of important events since September 2011 to continue ... SEQUOIA CAPITAL INVESTMENT ... announced the selection of Sequoia Capital as its investment ...
Cached Medicine Technology:White Smile Global Inc. Corporate Update on the White Smile Premier™ "At-Home" LED Teeth Whitening System and the White Smile Tooth Gloss™, Including Clinical Study, Product Manufacturing, and Distribution 2White Smile Global Inc. Corporate Update on the White Smile Premier™ "At-Home" LED Teeth Whitening System and the White Smile Tooth Gloss™, Including Clinical Study, Product Manufacturing, and Distribution 3Healthcare Quality Catalyst Partners With Sequoia, Adds Three Healthcare Veterans 2Healthcare Quality Catalyst Partners With Sequoia, Adds Three Healthcare Veterans 3Healthcare Quality Catalyst Partners With Sequoia, Adds Three Healthcare Veterans 4Healthcare Quality Catalyst Partners With Sequoia, Adds Three Healthcare Veterans 5
(Date:8/2/2015)... ... August 02, 2015 , ... Molecular biologists in New South ... for mesothelioma. Surviving Mesothelioma has just posted an article on the new research. ... South Wales tested for Ki67 expression in tissue samples from 42 patients with peritoneal ...
(Date:8/1/2015)... ... ... The condition where veins are enlarged and gnarled is known as varicose veins, ... who spend a lot of time on their feet and standing are even more ... can to create awareness and provide a cure in observance of Senior Citizen's Day ...
(Date:8/1/2015)... York, NY (PRWEB) , ... August 01, 2015 , ... ... Vine cyberespionage group , who are thought to have been behind the attack on ... the topics covered were zero day exploits, watering hole attacks and spear phishing campaigns. ...
(Date:7/31/2015)... ... 31, 2015 , ... That’s right, the STASH awards have ... The Significant Technological Achievements in Secretive Horticulture (or STASH) Awards, featured in High ... that have stood the test of time. These include lighting products, organic and ...
(Date:7/31/2015)... ... ... Ticket Down is a reliable source for authentic tickets for the 2015 ... festival will end on Sunday, August 2nd. , Music fans have traveled ... unique and unbelievably popular festival attracts the best in entertainment from around the world. ...
Breaking Medicine News(10 mins):Health News:Scientists Link Protein Marker with Mesothelioma Prognosis in New Study, According to Surviving Mesothelioma 2Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 2Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 2Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 4Health News:The High Times S.T.A.S.H. Awards Are in, Guess Who Took Home the Prize for “Best Grow System” 2Health News:Cheap 2015 Lollapalooza Tickets: Ticket Down Slashes Ticket Prices on Lollapalooza Tickets at Grant Park in Chicago for Saturday, August 1st and Sunday, August 2nd 2
... Online Survey Examines Current Standard of Care and ... Feb. 19 A recent survey of,202 neonatologists ... caring for the specialized health needs of preterm ... United States,healthcare system does not place enough emphasis ...
... who are overweight or obese have lower concentrations of ... counterparts, according to a new study led by Duke ... results on PSA concentrations found in obese and overweight ... reconsider PSA threshold values for heavier patients, and to ...
... to recent media,reports, Roche would like to reaffirm that ... for the 2007-2008,flu season, and that physicians and patients ... strikes., Some news reports have indicated "shortages" of ... place to ensure that Tamiflu is readily,available. If a ...
... to lead Diabetes Sales, Managed Care and Government ... ... Novo Nordisk, a,healthcare company with an 85-year history of innovation ... Pamela Harris as,vice president for Diabetes Sales, Managed Care and ...
... Florida Tissue,Services, a subsidiary of LifeNet Health ... Tissue Banks (AATB)., AATB inspectors examined ... of the Association,s Standards and policies, including,record-keeping, ... suitability determinations. Tissue banks receive accreditation,from the ...
... for Two-Week Eye Health Program,in Mandalay, NEW YORK, ... Health and the Mandalay Eye and ENT Hospital, ORBIS,International, ... returns to Myanmar to conduct its ninth Flying Eye,Hospital ... from February,25 to March 7, 2008., Working together ...
Cached Medicine News:Health News:Neonatologists and Pediatricians Highlight Progress and Barriers to Preemie Care 2Health News:Neonatologists and Pediatricians Highlight Progress and Barriers to Preemie Care 3Health News:Neonatologists and Pediatricians Highlight Progress and Barriers to Preemie Care 4Health News:Overweight and obese men have lower PSA values, even before they get prostate cancer 2Health News:Press Statement: Roche Affirms That Tamiflu(R) is in Ample Supply Nationwide 2Health News:Novo Nordisk Consolidates U.S. Diabetes Sales Leadership Under Single Vice President 2Health News:Florida Tissue Services Receives National Accreditation 2Health News:ORBIS International's Flying Eye Hospital Returns to Myanmar 2
... a patented Per-fit™ flexible PVC tube with ... cuff specifically designed to reduce insertion force ... anatomy. The kit s unique obturator/dilator design ... allowing for an easier transition through the ...
... Per-fit™ flexible PVC tube with a tapered ... designed to reduce insertion force and more ... kit s unique obturator/dilator design is engineered ... an easier transition through the tissue into ...
... Self-contained kits provide convenience and cost ... tracheostomy care trays offer a variety of ... and management of the tracheostomized patient. , ... trays, and trays with disposable inner cannula ...
... and cost control. , ,Our full ... variety of wound dressing components for the ... patient. , ,Tray configurations include full ... inner cannula for both rigid and flexible ...
Medicine Products: